(Mark One) | |||||
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which Registered | ||||||
Large accelerated filer | ☐ | ☒ | ||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||
Emerging growth company |
Page | |||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands, except per share amounts) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Product sales | $ | $ | $ | $ | |||||||||||||||||||
Services | |||||||||||||||||||||||
Total revenues | |||||||||||||||||||||||
Cost of revenues: | |||||||||||||||||||||||
Product sales | |||||||||||||||||||||||
Services | |||||||||||||||||||||||
Total cost of revenues | |||||||||||||||||||||||
Gross margin | |||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research and development | |||||||||||||||||||||||
Selling and administrative | |||||||||||||||||||||||
Restructuring charges (recovery) | ( | ||||||||||||||||||||||
Total operating expenses | |||||||||||||||||||||||
Operating income | |||||||||||||||||||||||
Interest expense, net | |||||||||||||||||||||||
Other expense, net | |||||||||||||||||||||||
Income (loss) before income taxes | ( | ||||||||||||||||||||||
Provision for (benefit from) income taxes | ( | ||||||||||||||||||||||
Net income (loss) | $ | $ | $ | ( | $ | ||||||||||||||||||
Net income (loss) per share of common stock outstanding: | |||||||||||||||||||||||
Basic | $ | $ | $ | ( | $ | ||||||||||||||||||
Diluted | $ | $ | $ | ( | $ | ||||||||||||||||||
Weighted-average shares outstanding: | |||||||||||||||||||||||
Basic | |||||||||||||||||||||||
Diluted |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Net income (loss) | $ | $ | $ | ( | $ | ||||||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Net change in cumulative translation adjustments | ( | ( | |||||||||||||||||||||
Other comprehensive income (loss) | ( | ( | |||||||||||||||||||||
Comprehensive income (loss) | $ | $ | $ | ( | $ | ||||||||||||||||||
(In thousands, except share and par value amounts) | March 28, 2025 | June 28, 2024 | |||||||||
ASSETS | |||||||||||
Current Assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable, net of allowances of $ | |||||||||||
Unbilled receivables | |||||||||||
Inventories | |||||||||||
Assets held for sale | |||||||||||
Other current assets | |||||||||||
Total current assets | |||||||||||
Property, plant and equipment, net | |||||||||||
Goodwill | |||||||||||
Intangible assets, net | |||||||||||
Deferred income taxes | |||||||||||
Right-of-use assets | |||||||||||
Other assets | |||||||||||
Total assets | $ | $ | |||||||||
LIABILITIES AND EQUITY | |||||||||||
Current Liabilities: | |||||||||||
Accounts payable | $ | $ | |||||||||
Accrued expenses | |||||||||||
Operating lease liabilities | |||||||||||
Advance payments and unearned revenue | |||||||||||
Other current liabilities | |||||||||||
Current portion of long-term debt | |||||||||||
Total current liabilities | |||||||||||
Long-term debt | |||||||||||
Unearned revenue | |||||||||||
Long-term operating lease liabilities | |||||||||||
Other long-term liabilities | |||||||||||
Reserve for uncertain tax positions | |||||||||||
Deferred income taxes | |||||||||||
Total liabilities | |||||||||||
Commitments and contingencies (Note 12) | |||||||||||
Stockholders’ equity: | |||||||||||
Preferred stock, $ | |||||||||||
Common stock, $ | |||||||||||
Treasury stock | ( | ( | |||||||||
Additional paid-in-capital | |||||||||||
Accumulated deficit | ( | ( | |||||||||
Accumulated other comprehensive loss | ( | ( | |||||||||
Total stockholders’ equity | |||||||||||
Total liabilities and stockholders’ equity | $ | $ |
Nine Months Ended | |||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | |||||||||
Operating Activities | |||||||||||
Net (loss) income | $ | ( | $ | ||||||||
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | |||||||||||
Depreciation of property, plant and equipment | |||||||||||
Amortization of intangible assets | |||||||||||
Provision for uncollectible receivables | |||||||||||
Share-based compensation | |||||||||||
Deferred taxes | ( | ||||||||||
Inventory write-downs | |||||||||||
Non-cash lease expense | |||||||||||
Loss on extinguishment of debt | |||||||||||
Other non-cash operating activities, net | |||||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | ( | ||||||||||
Unbilled receivables | ( | ( | |||||||||
Inventories | ( | ||||||||||
Accounts payable | ( | ||||||||||
Accrued expenses | ( | ||||||||||
Advance payments and unearned revenue | ( | ||||||||||
Income taxes payable | |||||||||||
Other assets and liabilities | ( | ( | |||||||||
Net cash (used in) provided by operating activities | ( | ||||||||||
Investing Activities | |||||||||||
Purchase of property, plant and equipment | ( | ( | |||||||||
Purchase of marketable securities | ( | ||||||||||
Proceeds from sale of asset held for sale | |||||||||||
Acquisition, net of cash acquired | ( | ( | |||||||||
Net cash used in investing activities | ( | ( | |||||||||
Financing Activities | |||||||||||
Proceeds from revolver | |||||||||||
Repayments of revolver | ( | ( | |||||||||
Proceeds from term loan | |||||||||||
Repayments of term loan | ( | ( | |||||||||
Payments of deferred financing costs | ( | ( | |||||||||
Payments of deferred consideration for acquisitions | ( | ||||||||||
Payments for repurchase of common stock - treasury shares | ( | ( | |||||||||
Payments for taxes related to net settlement of equity awards | ( | ( | |||||||||
Proceeds from issuance of common stock under employee stock plans | |||||||||||
Net cash provided by financing activities | |||||||||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | ( | ||||||||||
Net (decrease) increase in cash, cash equivalents, and restricted cash | ( | ||||||||||
Cash, cash equivalents, and restricted cash, beginning of period | |||||||||||
Cash, cash equivalents, and restricted cash, end of period | $ | $ | |||||||||
Supplemental disclosures of cash flow information | |||||||||||
Non-cash investing and financing activities: | |||||||||||
Common stock issued in connection with acquisition | $ | $ |
Three Months Ended March 28, 2025 | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Total Equity | ||||||||||||||||||||||||||||||||||||
(In thousands) | Shares | $ Amount | $ Amount | ||||||||||||||||||||||||||||||||||||||
Balance as of December 27, 2024 | $ | $ | ( | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Issuance of common stock under employee stock plans | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Shares withheld for taxes related to vesting of equity awards | ( | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||
Stock repurchase | ( | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Balance as of March 28, 2025 | $ | $ | ( | $ | $ | ( | $ | ( | $ |
Three Months Ended March 29, 2024 | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Total Equity | ||||||||||||||||||||||||||||||||||||
(In thousands) | Shares | $ Amount | $ Amount | ||||||||||||||||||||||||||||||||||||||
Balance as of December 29, 2023 | $ | $ | ( | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||
Issuance of common stock under employee stock plans | — | — | — | ||||||||||||||||||||||||||||||||||||||
Shares withheld for taxes related to vesting of equity awards | ( | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Balance as of March 29, 2024 | $ | $ | ( | $ | $ | ( | $ | ( | $ |
Nine Months Ended March 28, 2025 | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Total Equity | ||||||||||||||||||||||||||||||||||||
(In thousands) | Shares | $ Amount | $ Amount | ||||||||||||||||||||||||||||||||||||||
Balance as of June 28, 2024 | $ | $ | ( | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||
Issuance of common stock under employee stock plans | — | — | — | ||||||||||||||||||||||||||||||||||||||
Shares withheld for taxes related to vesting of equity awards | ( | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||
Stock repurchase | ( | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Balance as of March 28, 2025 | $ | $ | ( | $ | $ | ( | $ | ( | $ |
Nine Months Ended March 29, 2024 | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Total Equity | ||||||||||||||||||||||||||||||||||||
(In thousands) | Shares | $ Amount | $ Amount | ||||||||||||||||||||||||||||||||||||||
Balance as of June 30, 2023 | $ | $ | ( | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Issuance of common stock under employee stock plans | — | — | — | ||||||||||||||||||||||||||||||||||||||
Shares withheld for taxes related to vesting of equity awards | ( | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||
Stock repurchase | ( | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Common stock issued in connection with acquisition | — | — | — | ||||||||||||||||||||||||||||||||||||||
Balance as of March 29, 2024 | $ | $ | ( | $ | $ | ( | $ | ( | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands, except per share amounts) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net income (loss) | $ | $ | $ | ( | $ | ||||||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average shares outstanding, basic | |||||||||||||||||||||||
Effect of potentially dilutive equivalent shares | |||||||||||||||||||||||
Weighted-average shares outstanding, diluted | |||||||||||||||||||||||
Net income (loss) per share of common stock outstanding: | |||||||||||||||||||||||
Basic | $ | $ | $ | ( | $ | ||||||||||||||||||
Diluted | $ | $ | $ | ( | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Stock options | |||||||||||||||||||||||
Restricted stock units and performance stock units | |||||||||||||||||||||||
Total shares of common stock excluded |
(In thousands) | March 28, 2025 | June 28, 2024 | |||||||||
Contract assets | |||||||||||
Accounts receivable, net | $ | $ | |||||||||
Unbilled receivables | |||||||||||
Capitalized commissions | |||||||||||
Contract liabilities | |||||||||||
Advance payments and unearned revenue | $ | $ | |||||||||
Unearned revenue, long-term |
(In thousands) | March 28, 2025 | June 28, 2024 | |||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash included in long-term other assets | |||||||||||
Total cash, cash equivalents, and restricted cash | $ | $ |
(In thousands) | March 28, 2025 | June 28, 2024 | |||||||||
Finished products | $ | $ | |||||||||
Raw materials and supplies | |||||||||||
Customer service inventories | |||||||||||
Total inventories | $ | $ | |||||||||
Consigned inventories included within raw materials and supplies | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Excess and obsolete inventory | $ | $ | $ | $ | |||||||||||||||||||
Customer service inventory write-downs | |||||||||||||||||||||||
Total charges | $ | $ | $ | $ |
(In thousands) | March 28, 2025 | June 28, 2024 | |||||||||
Prepaid and other current assets | $ | $ | |||||||||
Taxes | |||||||||||
Contract manufacturing assets | |||||||||||
Total other current assets | $ | $ |
(In thousands) | March 28, 2025 | June 28, 2024 | |||||||||
Buildings and leasehold improvements | $ | $ | |||||||||
Software and equipment | |||||||||||
Total property, plant and equipment, gross | |||||||||||
Less: accumulated depreciation | ( | ( | |||||||||
Total property, plant and equipment, net | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Depreciation | $ | $ | $ | $ |
(In thousands) | March 28, 2025 | June 28, 2024 | |||||||||
Taxes | $ | $ | |||||||||
Compensation and benefits | |||||||||||
Project costs | |||||||||||
Warranties | |||||||||||
Professional fees | |||||||||||
Commissions | |||||||||||
Other | |||||||||||
Total accrued expenses | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Balance as of the beginning of the period | $ | $ | $ | $ | |||||||||||||||||||
Warranty provision recorded during the period | |||||||||||||||||||||||
Assumed in acquisition | |||||||||||||||||||||||
Consumption during the period | ( | ( | ( | ( | |||||||||||||||||||
Balance as of the end of the period | $ | $ | $ | $ |
(In thousands) | March 28, 2025 | June 28, 2024 | |||||||||
Advance payments | $ | $ | |||||||||
Unearned revenue | |||||||||||
Total advance payments and unearned revenue | $ | $ |
(In thousands) | March 28, 2025 | June 28, 2024 | Valuation Inputs | ||||||||||||||
Assets: | |||||||||||||||||
Cash and cash equivalents: | |||||||||||||||||
Money market funds | $ | $ | Level 1 | ||||||||||||||
Bank certificates of deposit | $ | $ | Level 2 | ||||||||||||||
(In thousands) | ||||||||
Revolver | $ | |||||||
Term loan | ||||||||
Less: unamortized deferred financing costs | ( | |||||||
Total debt | ||||||||
Less: current portion of long-term debt | ( | |||||||
Total long-term debt | $ |
(In thousands) | ||||||||
Remainder of 2025 | $ | |||||||
2026 | ||||||||
2027 | ||||||||
2028 | ||||||||
2029 | ||||||||
2030 | ||||||||
Total | $ |
(In thousands) | Employee Severance and Benefits | Facilities and Other | Total | ||||||||||||||
Balance as of June, 28, 2024 | $ | $ | $ | ||||||||||||||
Cash payments | ( | ( | |||||||||||||||
Balance as of September, 27, 2024 | $ | $ | $ | ||||||||||||||
Charges, net | |||||||||||||||||
Cash payments | ( | ( | |||||||||||||||
Balance as of December, 27, 2024 | $ | $ | $ | ||||||||||||||
Charges, net | |||||||||||||||||
Cash payments | ( | ( | |||||||||||||||
Balance as of March, 28, 2025 | $ | $ | $ | ||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
By Expense Category: | |||||||||||||||||||||||
Cost of revenues | $ | ( | $ | $ | $ | ||||||||||||||||||
Research and development | |||||||||||||||||||||||
Selling and administrative | |||||||||||||||||||||||
Total share-based compensation expense | $ | $ | $ | $ | |||||||||||||||||||
By Type of Award: | |||||||||||||||||||||||
Options | $ | $ | $ | $ | |||||||||||||||||||
Restricted stock and performance share awards and units | |||||||||||||||||||||||
Total share-based compensation expense | $ | $ | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
North America | $ | $ | $ | $ | |||||||||||||||||||
Africa and the Middle East | |||||||||||||||||||||||
Europe | |||||||||||||||||||||||
Latin America and Asia Pacific | |||||||||||||||||||||||
Total revenue | $ | $ | $ | $ |
(In thousands) | ||||||||
Cash and cash equivalents | $ | |||||||
Accounts receivable, net | ||||||||
Inventories | ||||||||
Property, plant and equipment, net | ||||||||
Identifiable finite-lived intangible assets: | ||||||||
Customer relationships | ||||||||
Technology | ||||||||
Trade names | ||||||||
Other assets | ||||||||
Accounts payable | ( | |||||||
Advance payments and unearned revenue | ( | |||||||
Other liabilities | ( | |||||||
Goodwill | ||||||||
Net assets acquired | $ |
(In thousands) | ||||||||
Accounts receivable, net | $ | |||||||
Inventories | ||||||||
Property, plant and equipment, net | ||||||||
Identifiable finite-lived intangible assets: | ||||||||
Customer relationships | ||||||||
Technology | ||||||||
Other assets | ||||||||
Accounts payable | ( | |||||||
Advance payments and unearned revenue | ( | |||||||
Other liabilities | ( | |||||||
Goodwill | ||||||||
Net assets acquired | $ |
Three Months Ended | Nine Months Ended | |||||||||||||
March 29, 2024 | March 29, 2024 | |||||||||||||
Revenue | $ | $ | ||||||||||||
Net income |
(In thousands) | March 28, 2025 | |||||||
Letters of credit | $ | |||||||
Bonds | ||||||||
$ |
(In thousands) | March 28, 2025 | June 28, 2024 | ||||||||||||||||||
Goodwill | $ | $ |
(In thousands except useful life) | Useful life in Years | March 28, 2025 | June 28, 2024 | |||||||||||||||||
Intangible assets: | ||||||||||||||||||||
Technology | $ | $ | ||||||||||||||||||
Patents | ||||||||||||||||||||
Customer relationships | ||||||||||||||||||||
Trade names | ||||||||||||||||||||
Total gross intangible assets | $ | $ | ||||||||||||||||||
Accumulated amortization | ( | ( | ||||||||||||||||||
Total net intangible assets | $ | $ |
Remainder of 2025 | $ | |||||||
2026 | ||||||||
2027 | ||||||||
2028 | ||||||||
2029 | ||||||||
Thereafter | ||||||||
Total | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In thousands) | March 28, 2025 | March 29, 2024 | March 28, 2025 | March 29, 2024 | |||||||||||||||||||
Transition services received | $ | $ | $ | $ | |||||||||||||||||||
Research and development services received | |||||||||||||||||||||||
Purchase of inventories |
(In thousands) | ||||||||
Accounts receivable, net | $ | |||||||
Accounts payable | ||||||||
Other current liabilities |
Three Months Ended March 29, 2024 | Nine Months Ended March 29, 2024 | ||||||||||||||||||||||||||||||||||
(In thousands, except per share amounts) | As Previously Reported | Adjustments | As Revised | As Previously Reported | Adjustments | As Revised | |||||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||||||||||
Product sales | $ | $ | ( | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Services | ( | ( | |||||||||||||||||||||||||||||||||
Total revenues | ( | ( | |||||||||||||||||||||||||||||||||
Cost of revenues: | |||||||||||||||||||||||||||||||||||
Product sales | ( | ( | |||||||||||||||||||||||||||||||||
Services | ( | ( | |||||||||||||||||||||||||||||||||
Total cost of revenues | ( | ( | |||||||||||||||||||||||||||||||||
Gross margin | ( | ( | |||||||||||||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||||||
Selling and administrative | ( | ||||||||||||||||||||||||||||||||||
Operating income | ( | ||||||||||||||||||||||||||||||||||
Income before income taxes | ( | ||||||||||||||||||||||||||||||||||
Provision for income taxes | ( | ||||||||||||||||||||||||||||||||||
Net income | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Net income per share of common stock outstanding: | |||||||||||||||||||||||||||||||||||
Basic | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Diluted | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Three Months Ended March 29, 2024 | Nine Months Ended March 29, 2024 | ||||||||||||||||||||||||||||||||||
(In thousands) | As Previously Reported | Adjustments | As Revised | As Previously Reported | Adjustments | As Revised | |||||||||||||||||||||||||||||
Net income | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Comprehensive income | $ | $ | $ | $ | $ | ( | $ |
Nine Months Ended March 29, 2024 | |||||||||||||||||
(In thousands) | As Previously Reported | Adjustments | As Revised | ||||||||||||||
Operating Activities | |||||||||||||||||
Net income | $ | $ | ( | $ | |||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
Deferred taxes | ( | ||||||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||||
Accounts receivable | |||||||||||||||||
Unbilled receivables | ( | ( | |||||||||||||||
Inventories | ( | ||||||||||||||||
Accrued expenses | ( | ||||||||||||||||
Net cash provided by operating activities | $ | $ | $ | ||||||||||||||
Three Months Ended March 29, 2024 | ||||||||||||||
Accumulated Deficit | Total Equity | |||||||||||||
(In thousands) | ||||||||||||||
As Previously Reported | ||||||||||||||
Balance as of December 29, 2023 | $ | ( | $ | |||||||||||
Net income | ||||||||||||||
Balance as of March 29, 2024 | $ | ( | $ | |||||||||||
Adjustments | ||||||||||||||
Balance as of December 29, 2023 | $ | ( | $ | ( | ||||||||||
Net income | ||||||||||||||
Balance as of March 29, 2024 | $ | ( | $ | ( | ||||||||||
As Revised | ||||||||||||||
Balance as of December 29, 2023 | $ | ( | $ | |||||||||||
Net income | ||||||||||||||
Balance as of March 29, 2024 | $ | ( | $ |
Nine Months Ended March 29, 2024 | ||||||||||||||
Accumulated Deficit | Total Equity | |||||||||||||
(In thousands) | ||||||||||||||
As Previously Reported | ||||||||||||||
Balance as of June 30, 2023 | $ | ( | $ | |||||||||||
Net income | ||||||||||||||
Balance as of March 29, 2024 | $ | ( | $ | |||||||||||
Adjustments | ||||||||||||||
Balance as of June 30, 2023 | $ | ( | $ | ( | ||||||||||
Net income | ( | ( | ||||||||||||
Balance as of March 29, 2024 | $ | ( | $ | ( | ||||||||||
As Revised | ||||||||||||||
Balance as of June 30, 2023 | $ | ( | $ | |||||||||||
Net income | ||||||||||||||
Balance as of March 29, 2024 | $ | ( | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
North America | $ | 49,402 | $ | 44,400 | $ | 5,002 | 11.3 | % | $ | 149,589 | $ | 149,868 | $ | (279) | (0.2) | % | |||||||||||||||||||||||||||||||
Africa and the Middle East | 15,086 | 11,401 | 3,685 | 32.3 | % | 38,210 | 35,848 | 2,362 | 6.6 | % | |||||||||||||||||||||||||||||||||||||
Europe | 9,429 | 6,549 | 2,880 | 44.0 | % | 23,376 | 17,378 | 5,998 | 34.5 | % | |||||||||||||||||||||||||||||||||||||
Latin America and Asia Pacific | 38,723 | 48,472 | (9,749) | (20.1) | % | 108,091 | 88,329 | 19,762 | 22.4 | % | |||||||||||||||||||||||||||||||||||||
Total revenue | $ | 112,640 | $ | 110,822 | $ | 1,818 | 1.6 | % | $ | 319,266 | $ | 291,423 | $ | 27,843 | 9.6 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Product sales | $ | 76,824 | $ | 70,844 | $ | 5,980 | 8.4 | % | $ | 220,252 | $ | 195,410 | $ | 24,842 | 12.7 | % | |||||||||||||||||||||||||||||||
Services | 35,816 | 39,978 | (4,162) | (10.4) | % | 99,014 | 96,013 | 3,001 | 3.1 | % | |||||||||||||||||||||||||||||||||||||
Total revenue | $ | 112,640 | $ | 110,822 | $ | 1,818 | 1.6 | % | $ | 319,266 | $ | 291,423 | $ | 27,843 | 9.6 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Revenue | $ | 112,640 | $ | 110,822 | $ | 1,818 | 1.6 | % | $ | 319,266 | $ | 291,423 | $ | 27,843 | 9.6 | % | |||||||||||||||||||||||||||||||
Cost of revenue | 73,344 | 74,751 | (1,407) | (1.9) | % | 219,296 | 187,830 | 31,466 | 16.8 | % | |||||||||||||||||||||||||||||||||||||
Gross margin | $ | 39,296 | $ | 36,071 | $ | 3,225 | 8.9 | % | $ | 99,970 | $ | 103,593 | $ | (3,623) | (3.5) | % | |||||||||||||||||||||||||||||||
% of revenue | 34.9 | % | 32.5 | % | 31.3 | % | 35.5 | % | |||||||||||||||||||||||||||||||||||||||
Product margin % | 33.1 | % | 32.6 | % | 28.0 | % | 38.1 | % | |||||||||||||||||||||||||||||||||||||||
Service margin % | 38.6 | % | 32.5 | % | 38.6 | % | 30.4 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Research and development | $ | 7,704 | $ | 10,623 | $ | (2,919) | (27.5) | % | $ | 28,334 | $ | 25,441 | $ | 2,893 | 11.4 | % | |||||||||||||||||||||||||||||||
% of revenue | 6.8 | % | 9.6 | % | 8.9 | % | 8.7 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Selling and administrative | $ | 22,121 | $ | 20,198 | $ | 1,923 | 9.5 | % | $ | 68,348 | $ | 61,979 | $ | 6,369 | 10.3 | % | |||||||||||||||||||||||||||||||
% of revenue | 19.6 | % | 18.2 | % | 21.4 | % | 21.3 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Restructuring charges | $ | 177 | $ | (417) | $ | 594 | (142.4) | % | $ | 1,592 | $ | 2,227 | $ | (635) | (28.5) | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Interest expense, net | $ | 1,557 | $ | 928 | $ | 629 | 67.8 | % | $ | 4,252 | $ | 1,421 | $ | 2,831 | 199.2 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Other expense, net | $ | 3,068 | $ | 63 | $ | 3,005 | 4,769.8 | % | $ | 4,047 | $ | 228 | $ | 3,819 | 1,675.0 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
(In thousands, except percentages) | March 28, 2025 | March 29, 2024 | $ Change | % Change | March 28, 2025 | March 29, 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||
Income (loss) before income taxes | $ | 4,669 | $ | 4,676 | $ | (7) | (0.1) | % | $ | (6,603) | $ | 12,297 | $ | (18,900) | (153.7) | % | |||||||||||||||||||||||||||||||
Provision for (benefit from) income taxes | $ | 1,141 | $ | 806 | $ | 335 | 41.6 | % | $ | (2,747) | $ | 3,086 | $ | (5,833) | (189.0) | % |
Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet be Purchased Under the Program (in thousands) | |||||||||||||||||||
December 28, 2024 — January 24, 2025 | — | $ | — | — | $ | 6,429 | |||||||||||||||||
January 25, 2025 — February 21, 2025 | — | — | — | 6,429 | |||||||||||||||||||
February 22, 2025 — March 28, 2025 | 5,200 | 19.12 | 5,200 | 6,330 | |||||||||||||||||||
Total | 5,200 | 5,200 | $ | 6,330 | |||||||||||||||||||
Exhibit Number | Descriptions | |||||||
3.1 | ||||||||
3.2 | ||||||||
31.1* | ||||||||
31.2* | ||||||||
32.1** | ||||||||
101.INS | XBRL Instance Document | |||||||
101.SCH | XBRL Taxonomy Extension Schema Document | |||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||
* | Filed herewith. | |||||||
** | Furnished herewith. |
AVIAT NETWORKS, INC. (Registrant) |
By: | /s/ Michael Connaway | ||||
Michael Connaway Senior Vice President and Chief Financial Officer (duly authorized officer) |
Date: | May 6, 2025 | /s/ Peter A. Smith | ||||||||||||
Name: | Peter A. Smith | |||||||||||||
Title: | President and Chief Executive Officer |
Date: | May 6, 2025 | /s/ Michael Connaway | ||||||||||||
Name: | Michael Connaway | |||||||||||||
Title: | Senior Vice President and Chief Financial Officer |
Date: May 6, 2025 | /s/ Peter A. Smith | |||||||
Name: Peter A. Smith | ||||||||
Title: President and Chief Executive Officer |
Date: May 6, 2025 | /s/ Michael Connaway | |||||||
Name: Michael Connaway | ||||||||
Title: Senior Vice President and Chief Financial Officer |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Revenues: | ||||
Total revenues | $ 112,640 | $ 110,822 | $ 319,266 | $ 291,423 |
Cost of revenues: | ||||
Total cost of revenues | 73,344 | 74,751 | 219,296 | 187,830 |
Gross margin | 39,296 | 36,071 | 99,970 | 103,593 |
Operating expenses: | ||||
Research and development | 7,704 | 10,623 | 28,334 | 25,441 |
Selling and administrative | 22,121 | 20,198 | 68,348 | 61,979 |
Restructuring charges (recovery) | 177 | (417) | 1,592 | 2,227 |
Total operating expenses | 30,002 | 30,404 | 98,274 | 89,647 |
Operating income | 9,294 | 5,667 | 1,696 | 13,946 |
Interest expense, net | 1,557 | 928 | 4,252 | 1,421 |
Other expense, net | 3,068 | 63 | 4,047 | 228 |
Income (loss) before income taxes | 4,669 | 4,676 | (6,603) | 12,297 |
Provision for (benefit from) income taxes | 1,141 | 806 | (2,747) | 3,086 |
Net income (loss), basic | 3,528 | 3,870 | (3,856) | 9,211 |
Net income (loss), diluted | $ 3,528 | $ 3,870 | $ (3,856) | $ 9,211 |
Net income (loss) per share of common stock outstanding: | ||||
Basic (in dollars per share) | $ 0.28 | $ 0.31 | $ (0.30) | $ 0.76 |
Diluted (in dollars per share) | $ 0.27 | $ 0.30 | $ (0.30) | $ 0.75 |
Weighted-average shares outstanding: | ||||
Basic (in shares) | 12,689 | 12,555 | 12,672 | 12,043 |
Diluted (in shares) | 12,838 | 12,779 | 12,672 | 12,325 |
Product sales | ||||
Revenues: | ||||
Total revenues | $ 76,824 | $ 70,844 | $ 220,252 | $ 195,410 |
Cost of revenues: | ||||
Total cost of revenues | 51,370 | 47,783 | 158,540 | 120,989 |
Services | ||||
Revenues: | ||||
Total revenues | 35,816 | 39,978 | 99,014 | 96,013 |
Cost of revenues: | ||||
Total cost of revenues | $ 21,974 | $ 26,968 | $ 60,756 | $ 66,841 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Statement of Comprehensive Income [Abstract] | ||||
Net income (loss) | $ 3,528 | $ 3,870 | $ (3,856) | $ 9,211 |
Other comprehensive income (loss): | ||||
Net change in cumulative translation adjustments | 1,108 | (341) | (155) | 237 |
Other comprehensive income (loss) | 1,108 | (341) | (155) | 237 |
Comprehensive income (loss) | $ 4,636 | $ 3,529 | $ (4,011) | $ 9,448 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ 3,122 | $ 1,854 |
Preferred stock par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 50,000,000.0 | 50,000,000.0 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Common stock par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 300,000,000.0 | 300,000,000.0 |
Common stock, shares issued (in shares) | 12,700,000 | 12,600,000 |
Common stock, shares outstanding (in shares) | 12,700,000 | 12,600,000 |
Treasury stock (in shares) | 200,000 | 200,000 |
The Company and Basis of Presentation |
9 Months Ended |
---|---|
Mar. 28, 2025 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
The Company and Basis of Presentation | The Company and Basis of Presentation The Company Aviat Networks, Inc. (“Aviat,” the “Company,” “we,” “us,” and “our”) designs, manufactures, and sells wireless networking and access networking solutions and services to mobile and fixed telephone service providers, private network operators, government agencies, transportation and utility companies, public safety agencies and broadcast system operators across the globe. Aviat’s products include broadband wireless access base stations and customer premises equipment for fixed and mobile, point-to-point digital microwave radio systems for access, backhaul, trunking and license-exempt applications, supporting new network deployments, network expansion, and capacity upgrades. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information, and Aviat has made estimates, assumptions and judgments affecting the amounts reported in its unaudited condensed consolidated financial statements and the accompanying notes, as discussed in greater detail below. Accordingly, the statements do not include all information and footnotes required by U.S. GAAP for annual consolidated financial statements. In the opinion of the Company’s management, such interim financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of its financial position, results of operations and cash flows for such periods. The results for the nine months ended March 28, 2025 are not necessarily indicative of the results that may be expected for the full fiscal year or future operating periods. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and footnotes thereto included in Aviat’s Annual Report on Form 10-K for the fiscal year ended June 28, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and accounts have been eliminated. Certain amounts in the financial statements have been reclassified for comparative purposes to conform to the current period financial statement presentation. Aviat’s fiscal year includes 52 or 53 weeks and ends on the Friday nearest to June 30. The three months ended March 28, 2025 and March 29, 2024 both consisted of 13 weeks. Fiscal year 2025 contains 52 weeks and will end on June 27, 2025. Fiscal year 2024 contained 52 weeks and ended on June 28, 2024. Use of Estimates The preparation of unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires the Company to make estimates, assumptions and judgments affecting the amounts reported and related disclosures. Estimates are based upon historical factors, current circumstances and the experience and judgment of the Company’s management. The Company evaluates estimates and assumptions on an ongoing basis and may employ outside experts to assist in making these evaluations. Changes in such estimates, based on more accurate information, or different assumptions or conditions, may affect amounts reported in future periods. Such estimates affect significant items, including revenue recognition, provision for uncollectible receivables, inventory valuation, goodwill and identified intangible assets in business combinations, valuation allowances for deferred tax assets, uncertainties in income taxes, contingencies and recoverability of long-lived assets. Actual results may differ materially from estimates. Revisions to Prior Period Consolidated Financial Statements Subsequent to the third quarter of fiscal 2024, the Company identified certain errors in the quarterly financial statements for fiscal 2024. In accordance with ASC 250, Accounting Changes and Error Corrections and Staff Accounting Bulletins (“SAB”) No. 99, Materiality and No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, the Company evaluated the materiality of the errors and determined that the impacts were not material, individually or in the aggregate, to the Company’s previously issued consolidated financial statements. As a result, the Company has revised the prior period financial statements and related disclosures to correct the errors for comparability across all periods presented herein. Refer to Note 15. Revisions to Prior Period Consolidated Financial Statements of the Notes to this Form 10-Q, and Note 1. The Company and Summary of Significant Accounting Policies and Part II, Item 9B. Other Information of the Company’s Annual Report on Form 10-K for the fiscal year ended June 28, 2024 for further information. Summary of Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies as of and for the nine months ended March 28, 2025, as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the fiscal year ended June 28, 2024. Accounting Standards Not Yet Adopted In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03 (Subtopic 220-40): Disaggregation of Income Statement Expenses. The ASU requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company’s annual reporting beginning in fiscal 2028 and for interim periods beginning in fiscal 2029. The Company is currently evaluating the impact of this ASU on its consolidated financial statements and disclosures. In December 2023, the FASB ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU enhances the transparency and usefulness of income tax information through improvements to disclosures primarily related to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for the Company’s annual reporting beginning in fiscal 2026. The Company is currently evaluating the impact of this ASU on its consolidated financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses that are regularly presented to the chief operating decision maker. The disclosures required under ASU 2023-07 are also required for public entities with a single reportable segment. ASU 2023-07 is effective for the Company’s annual reporting beginning in fiscal 2025 and for interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of the ASU on its consolidated financial statements and disclosures. The Company considers the applicability and impact of all ASUs issued by the FASB. The Company determined at this time that all other ASUs issued but not yet adopted are either not applicable or are expected to have a minimal impact on its financial position and results of operations.
|
Net Income (Loss) Per Share of Common Stock |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income (Loss) Per Share of Common Stock | Net Income (Loss) Per Share of Common Stock The following table presents the computation of basic and diluted net income (loss) per share:
The following table summarizes the weighted-average equity awards that were excluded from the diluted net income (loss) per share calculations since they were anti-dilutive:
|
Revenue Recognition |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition | Revenue Recognition Contract Balances, Performance Obligations, and Backlog
Significant changes in contract balances may arise as a result of recognition over time for services, transfer of control for equipment, and periodic payments (both in arrears and in advance). From time to time, the Company may experience unforeseen events that could result in a change to the scope or price associated with an arrangement. When such events occur, the transaction price and measurement of progress for the performance obligation are updated and this change is recognized as a cumulative catch-up to revenue. Because of the nature and type of contracts, the timeframe to completion and satisfaction of current and future performance obligations can shift; however, this will have no impact on the Company’s future obligation to bill and collect. As of March 28, 2025, the Company reported $93.3 million in advance payments and unearned revenue and long-term unearned revenue, of which approximately 70% is expected to be recognized as revenue in the next twelve months and the remainder thereafter. Approximately $10.4 million and $43.6 million of revenue was recognized during the three and nine months ended March 28, 2025, respectively, which was included in advance payments and unearned revenue at June 28, 2024. Remaining Performance Obligations The aggregate amount of transaction price allocated to unsatisfied (or partially unsatisfied) performance obligations was approximately $149.6 million at March 28, 2025 relating to our long-term field service projects. Of this amount, approximately 50% is expected to be recognized as revenue during the next 12 months, with the remaining amount to be recognized thereafter.
|
Balance Sheet Components |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Related Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Components | Balance Sheet Components Cash, Cash equivalents, and Restricted cash The following provides a summary of cash, cash equivalents, and restricted cash reported within the unaudited condensed consolidated balance sheets that reconciles to the corresponding amount in the unaudited condensed consolidated statement of cash flows:
Inventories
The Company records charges to adjust inventories due to excess and obsolete inventory resulting from lower sales forecasts, product transitioning or discontinuance. The charges incurred during the three and nine months ended March 28, 2025 and March 29, 2024 were included in cost of product sales as follows:
Other Current Assets
Property, Plant and Equipment, net
Included in the total property, plant and equipment, gross were $7.7 million and $4.1 million of assets in progress which have not been placed in service as of March 28, 2025 and June 28, 2024, respectively. Depreciation expense related to property, plant and equipment, was as follows:
Accrued Expenses
The Company accrues for the estimated cost to repair or replace products under warranty. Changes in the warranty liability were as follows:
Advance Payments and Unearned Revenue
Excluded from the balances above are $7.7 million and $7.4 million in long-term unearned revenue as of March 28, 2025 and June 28, 2024, respectively.
|
Fair Value Measurements of Assets and Liabilities |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements of Assets and Liabilities | Fair Value Measurements of Assets and Liabilities Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal market (or most advantageous market in the absence of a principal market) for the asset or liability in an orderly transaction between market participants as of the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs in measuring fair value and established a three-level fair value hierarchy that prioritizes the observable inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows: •Level 1 — Observable inputs such as quoted prices in active markets for identical assets or liabilities; •Level 2 — Observable market-based inputs or observable inputs that are corroborated by market data; and •Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The estimated fair values and valuation input levels of assets and liabilities that are measured at fair value on a recurring basis as of March 28, 2025 and June 28, 2024 were as follows:
Items are classified within Level 1 if quoted prices are available in active markets. The Company’s Level 1 items are primarily money market funds and marketable securities. As of March 28, 2025 and June 28, 2024, the money market funds were valued at $1.00 net asset value per share. Items are classified within Level 2 if the observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources are available with reasonable levels of price transparency. The Company’s bank certificates of deposit are classified within Level 2. The carrying value of bank certificates of deposit approximates their fair value. The Company did not have any recurring assets or liabilities that were valued using significant unobservable inputs.
|
Credit Facility and Debt |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit Facility and Debt | Credit Facility and Debt The Company entered into a Secured Credit Facility Agreement (the “Credit Facility”), dated May 9, 2023, amended as of November 22, 2023 and October 18, 2024, with Wells Fargo Bank, National Association, as administrative agent, swingline lender and issuing lender and Wells Fargo Securities LLC, Citigroup Global Markets Inc., and Regions Capital Markets as lenders. The Credit Facility provides for a $75.0 million revolving credit facility (the “Revolver”) and a $75.0 million Term Loan Facility (the “Term Loan”) with a maturity date of October 18, 2029. The $75.0 million Revolver can be borrowed with a $10.0 million sub-limit for letters of credit, and a $10.0 million swingline loan sub-limit. In November 2023, the Company borrowed $50.0 million against the Term Loan to primarily settle the cash portion of the consideration associated with the NEC Transaction (as defined below). See Note 11. Acquisitions for further information. As of March 28, 2025, the available credit under the Revolver was $66.3 million, reflecting the available limit of $75.0 million less outstanding letters of credit of $8.7 million. The Company borrowed and repaid $55.0 million against the Revolver during the nine months ended March 28, 2025. The Company borrowed $75.0 million and repaid $49.7 million against the Term Loan during the nine months ended March 28, 2025. The following summarizes the Company’s outstanding long-term debt as of March 28, 2025:
Outstanding borrowings under the Credit Facility bear interest at either: (a) Adjusted Term Secured Overnight Financing Rate (“SOFR”) plus the applicable margin; or (b) the Base Rate plus the applicable margin. The pricing levels for interest rate margins are determined based on the Consolidated Total Leverage Ratio as determined and adjusted quarterly. As of March 28, 2025, the applicable margin on Adjusted Term SOFR and Base Rate borrowings was 2.75% and 1.75%, respectively. The effective rate of interest on the outstanding Term Loan borrowings as of March 28, 2025 was 7.1%. The Credit Facility requires the Company and its subsidiaries to maintain a fixed charge coverage ratio to be greater than 1.25 to 1.00 as of the last day of any fiscal quarter of the Company. The Credit Facility also requires that the Company maintain a maximum leverage ratio of 3.00 times EBITDA, with a step-down to 2.75 times EBITDA after four full quarters, and 2.50 times EBITDA after eight full quarters. The Credit Facility contains customary affirmative and negative covenants, including, among others, covenants limiting the ability of the Company and its subsidiaries to dispose of assets, permit a change in control, merge or consolidate, make acquisitions, incur indebtedness, grant liens, make investments, make certain restricted payments, and enter into transactions with affiliates, in each case subject to customary exceptions. As of March 28, 2025, the Company was in compliance with all financial covenants contained in the Credit Facility. As of March 28, 2025, scheduled maturities of outstanding long-term debt by fiscal year are as follows:
|
Restructuring |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring | Restructuring The following table summarizes restructuring related activities during the nine months ended March 28, 2025:
As of March 28, 2025, the accrued restructuring balance of $0.1 million was included in other current liabilities on the unaudited condensed consolidated balance sheets. Included in the above were positions identified for termination that have not been executed from a restructuring perspective. Fiscal 2025 Plans During fiscal 2025, the Company’s Board of Directors approved restructuring plans, primarily associated with reductions in workforce in certain of the Company’s operations to optimize skill sets and align cost structure. The fiscal 2025 plans are expected to be completed through the end of fiscal 2025. Prior Years’ Plans During fiscal 2024, the Company’s Board of Directors approved restructuring plans, primarily associated with the NEC Transaction (as defined below) and reductions in workforce in certain of the Company’s operations to optimize skill sets and align cost structure. The fiscal 2024 plans are expected to be completed through the end of fiscal 2025.
|
Stockholders’ Equity |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders’ Equity | Stockholders’ Equity Stock Repurchase Program In November 2021, the Company’s Board of Directors approved a stock repurchase program to purchase up to $10.0 million of the Company’s common stock. As of March 28, 2025, $6.3 million remains available and Aviat may choose to suspend or discontinue the repurchase program at any time. Repurchased shares are recorded as treasury stock. During the third quarter of fiscal 2025, the Company repurchased 5,200 shares of its common stock in the open market for an aggregate purchase price, including commissions, of $0.1 million. Stock Incentive Programs As of March 28, 2025, the Company had one stock incentive plan for its employees and non-employee directors, the 2018 Incentive Plan (the “2018 Plan”). The 2018 Plan provides for the issuance of share-based awards in the form of stock options, stock appreciation rights, restricted stock awards and units, and performance share awards and units. Under the 2018 Plan, option exercise prices are equal to the fair market value of Aviat common stock on the date the options are granted using the closing stock price. After vesting, options generally may be exercised within seven years after the date of grant. Restricted stock units are not transferable until vested and the restrictions lapse upon the achievement of continued employment or service over a specified time period. Restricted stock units issued to employees generally vest three years from the date of grant (three-year cliff or annually over three years). Restricted stock units issued annually to non-executive board members generally vest on the day before the annual stockholders’ meeting. Vesting of performance share awards and units is subject to the achievement of predetermined financial performance and share price criteria, and continued employment through the end of the applicable period. During the nine months ended March 28, 2025, the Company granted 281,659 restricted stock units and 164,553 performance share awards. The Company recognizes compensation cost for share-based payment awards on a straight-line basis over the requisite service period. For awards with a performance condition vesting feature, share-based compensation costs are recognized when achievement of the performance conditions is considered probable. Forfeitures are recognized as they occur. Total compensation expense for share-based awards included in the unaudited condensed consolidated statements of operations was as follows:
As of March 28, 2025, there was approximately $1.1 million of total unrecognized compensation expense related to non-vested stock options granted which is expected to be recognized over a weighted-average period of 1.2 years. As of March 28, 2025, there was $10.6 million of total unrecognized compensation expense related to non-vested stock awards which is expected to be recognized over a weighted-average period of 1.8 years.
|
Segment and Geographic Information |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment and Geographic Information | Segment and Geographic Information Aviat operates in one reportable business segment: the design, manufacturing, and sale of wireless networking products, solutions, and services. The Company’s financial performance is regularly reviewed by its chief operating decision maker who is its Chief Executive Officer (“CEO”). The Company reports revenue by region and country based on the location where its customers accept delivery of products and services. Revenue by region for the three and nine months ended March 28, 2025 and March 29, 2024 was as follows:
|
Income Taxes |
9 Months Ended |
---|---|
Mar. 28, 2025 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company’s effective tax rate varies from the U.S. federal statutory rate of 21% primarily due to U.S. global intangible low-taxed income inclusion (GILTI), state taxes, stock-based compensation and foreign operations that are subject to income taxes at different statutory rates. During interim periods, tax expense or benefit are accrued for jurisdictions that are anticipated to be profitable for fiscal 2025. The determination of income taxes for the nine months ended March 28, 2025 and March 29, 2024 was based on the Company’s estimated annual effective tax rate adjusted for losses in certain jurisdictions for which no tax benefit can be recognized. The tax benefit for the nine months ended March 28, 2025 was primarily due to tax benefit resulting from year-to-date losses. The tax expense for the nine months ended March 29, 2024 was primarily due to tax expense related to U.S. and profitable foreign subsidiaries. The Company has a number of years with open tax audits which vary from jurisdiction to jurisdiction. The major tax jurisdictions that are open and subject to potential audits include the U.S., Singapore, Kenya, Nigeria, Saudi Arabia and Tanzania. The earliest years for these jurisdictions are as follows: U.S. - 2003; Singapore - 2015; Kenya – 2023; Nigeria – 2006; Saudi Arabia – 2019 and Tanzania - 2019. Interest and penalties related to unrecognized tax benefits are accounted for as part of the provision for federal, foreign, and state income taxes. Such interest expense was not material for the nine months ended March 28, 2025 and March 29, 2024. On March 11, 2021, the U.S. enacted the American Rescue Plan Act of 2021 (“ARPA”) which expands Section 162(m) to cover the next five most highly compensated employees for the taxable year, in addition to the “covered employees” effective for taxable years beginning after December 31, 2026. The Company will continue to examine the elements of the ARPA and the impact it may have on future business.
|
Acquisitions |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions | Acquisitions 4RF Limited On July 2, 2024, the Company acquired 4RF Limited (“4RF”), a New Zealand company. Aviat purchased all of the issued and outstanding shares of 4RF in an all-cash transaction for $18.2 million, net of $1.2 million cash acquired. 4RF is a leading provider of industrial wireless access solutions, including narrowband point-to-point/multi-point radios and Private LTE and 5G routers. The acquisition of 4RF allows Aviat to expand its product offering for the global industrial wireless access markets including Private LTE/5G. The 4RF acquisition was accounted for as a business combination using the acquisition method of accounting. The Company is in the process of obtaining independent third-party valuations of the intangible and tangible assets acquired. The fair values of the acquired intangible assets are based on estimates and assumptions that are considered reasonable to the Company. A summary of the preliminary purchase price allocation is as follows:
The preliminary purchase price allocation has been updated for certain measurement period adjustments based on revised estimates of fair value, which primarily resulted in a $0.9 million decrease in identifiable finite-lived intangible assets acquired, a $0.2 million increase in other assets and a $0.7 million increase to goodwill. The preliminary purchase price allocation is subject to adjustment based on the Company obtaining final independent third-party valuations and determining fair value and final allocations of purchase price to the identifiable assets acquired and liabilities assumed. The goodwill from this acquisition is non-deductible for tax purposes. NEC’s Wireless Transport Business On May 9, 2023, the Company entered into a Master Sale of Business Agreement (as amended on November 30, 2023, the “Purchase Agreement”) with NEC Corporation (“NEC”), to acquire NEC’s wireless transport business (the “NEC Transaction”). The Company completed the NEC Transaction on November 30, 2023 (the “Closing Date”). Prior to the Closing Date, NEC was a leader in wireless backhaul networks with an extensive installed base of their Pasolink series products. The completion of the NEC Transaction increases the scale of Aviat, enhances the Company’s product portfolio with a greater capability to innovate, and creates a more diversified business. The results of operations of the NEC Transaction have been included in the consolidated financial statements since the Closing Date. The fair value of the consideration transferred at the closing of the NEC Transaction was comprised of (i) cash of $32.2 million, and (ii) the issuance of 736,750 shares or $22.3 million of common stock of the Company. The fair value of the shares issued was determined based on the closing market price of the Company’s common stock on the Closing Date. Aggregate consideration transferred at closing was approximately $54.5 million, which was subject to certain post-closing adjustments. The Company funded the cash portion of the consideration transferred at closing primarily with Term Loan borrowings under its Credit Facility. See Note 6. Credit Facility and Debt for further information. In the second quarter of fiscal 2025, the Company transferred consideration of $5.8 million to settle a portion of the post-closing working capital adjustment. As of March 28, 2025, the Company recorded accruals of approximately $13.2 million in estimated additional cash consideration, which is included in other current liabilities on the unaudited condensed consolidated balance sheets. The additional consideration is primarily related to the settlement of the remaining post-closing working capital adjustment. The NEC Transaction was accounted for as a business combination using the acquisition method of accounting. The Company has obtained final independent third-party valuations of the intangible and tangible assets acquired. The fair values of the acquired intangible assets are based on estimates and assumptions that are considered reasonable by the Company. As of the acquisition date, the Company has recorded the assets acquired and the liabilities assumed at their respective estimated fair values. The recognized goodwill is attributable to the workforce of the acquired business and expected synergies. The goodwill from this acquisition is expected to be fully deductible for tax purposes. A summary of the final purchase price allocation is as follows:
The following unaudited supplemental pro forma information has been presented as if the NEC Transaction occurred at the beginning of fiscal 2023 and includes certain pro forma adjustments for interest expense, depreciation and amortization expense, the fair value of acquired inventory, and transaction costs, net of income tax:
The unaudited pro forma information presented above is for informational purposes only and is not necessarily indicative of the operating results that would have occurred if the NEC Transaction occurred at the beginning of fiscal 2023, nor is it necessarily indicative of future operating results.
|
Commitments and Contingencies |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies Purchase Orders and Other Commitments From time to time in the normal course of business, the Company may enter into purchasing agreements with its suppliers that require the Company to accept delivery of and remit full payment for (i) finished products that it has ordered, (ii) finished products that it requested be held as safety stock, and (iii) work in process started on its behalf, in the event it cancels or terminates the purchasing agreement. Because these agreements do not specify fixed or minimum quantities, do not specify minimum or variable price provisions, and do not specify the approximate timing of the transaction, and the Company has no present intention to cancel or terminate any of these agreements, the Company currently does not believe that it has any future liability under these agreements. As of March 28, 2025, the Company had outstanding purchase obligations with its suppliers or contract manufacturers of $45.0 million. In addition, the Company had purchase obligations of approximately $6.5 million associated with software as a service and software maintenance support. Financial Guarantees and Commercial Commitments Guarantees issued by banks, insurance companies, or other financial institutions are contingent commitments issued to guarantee performance under borrowing arrangements, such as bank overdraft facilities, tax and customs obligations, and similar transactions, or to ensure performance under customer or vendor contracts. The terms of the guarantees are generally equal to the remaining term of the related debt or other obligations and are generally limited to two years or less. As of March 28, 2025, the Company had no guarantees applicable to its debt arrangements. The Company has entered into commercial commitments in the normal course of business including surety bonds, standby letters of credit agreements, and other arrangements with financial institutions primarily relating to the guarantee of future performance on certain contracts to provide products and services to customers. As of March 28, 2025, the Company had commercial commitments outstanding of $24.1 million, that were not recorded on the unaudited condensed consolidated balance sheets. The Company does not believe, based on historical experience and information currently available, that it is probable that any significant amounts will be required to be paid on these performance guarantees in the future. The following table presents details of the Company’s commercial commitments:
Indemnifications Under the terms of substantially all of the Company’s license agreements, it has agreed to defend and pay any final judgment against its customers arising from claims against such customers that the Company’s products infringe the intellectual property rights of a third party. As of March 28, 2025, the Company has not received any notice that any customer is subject to an infringement claim arising from the use of its products; the Company has not received any request to defend any customers from infringement claims arising from the use of its products; and the Company has not paid any final judgment on behalf of any customer related to an infringement claim arising from the use of its products. Because the outcome of infringement disputes is related to the specific facts of each case and given the lack of previous or current indemnification claims, the Company cannot estimate the maximum amount of potential future payments, if any, related to its indemnification provisions. As of March 28, 2025, the Company had not recorded any liabilities related to these indemnifications. Legal Proceedings The Company is subject from time to time to disputes with customers concerning its products and services. From time to time, the Company may be involved in various other legal claims and litigation that arise in the normal course of its operations. The Company is aggressively defending all current litigation matters. Although there can be no assurances and the outcome of these matters is currently not determinable, the Company currently believes that none of these claims or proceedings are likely to have a material adverse effect on its financial position. There are many uncertainties associated with any litigation and these actions or other third-party claims against the Company may cause it to incur costly litigation and/or substantial settlement charges. As a result, the Company’s business, financial condition, results of operations, and cash flows could be adversely affected. The actual liability in any such matters may be materially different from the Company’s estimates, if any. The Company records accruals for its outstanding legal proceedings, investigations or claims when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated. The Company evaluates, at least on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would result in a loss contingency to become both probable and reasonably estimable. The Company has not recorded any significant accrual for loss contingencies associated with such legal claims or litigation discussed above. Contingent Liabilities The Company records a loss contingency as a charge to operations when (i) it is probable that an asset has been impaired or a liability has been incurred at the date of the financial statements; and (ii) the amount of the loss can be reasonably estimated. Disclosure in the notes to the financial statements is required for loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized. The Company expenses all legal costs incurred to resolve regulatory, legal and tax matters as incurred. In March 2016, an enforcement action by the Indian Department of Revenue, Ministry of Finance was brought against Aviat’s subsidiary Aviat Networks (India) Private Limited (“Aviat India”) relating to the non-realization of intercompany receivables and non-payment of intercompany payables, which originated from 1999 to 2012, within the time frames dictated by the Indian regulations under the Foreign Exchange Management Act. In November 2017, the Indian Department of Revenue, Ministry of Finance also initiated a similar action against Telsima Communications Private Limited (“Telsima India”), a subsidiary of the Company, relating to the non-realization of intercompany receivables and non-payment of intercompany payables which originated from the period prior to our acquisition of Telsima India in February 2009. In September 2019, the directors of Aviat India appeared before the Ministry of Finance Enforcement Directorate. In March 2024, the Company appeared before the Joint Director of Enforcement to review the transactions at issue. No subsequent hearing date has been scheduled as of March 28, 2025. The Company has accrued an immaterial amount representing the estimated probable loss for which it would settle the matter. The Company currently cannot form an estimate of the range of loss in excess of its amounts already accrued. If the outcome of this matter is greater than the current immaterial amount accrued, the Company intends to dispute it vigorously. Periodically, the Company reviews the status of each significant matter to assess the potential financial exposure. If a potential loss is considered probable and the amount can be reasonably estimated, the estimated loss is reflected in our results of operations. Significant judgment is required to determine the probability that a liability has been incurred or an asset impaired and whether such loss is reasonably estimable. Further, estimates of this nature are highly subjective, and the final outcome of these matters could vary significantly from the amounts that have been included in the consolidated financial statements. As additional information becomes available, the Company will reassess the potential liability related to its pending claims and litigation and may revise estimates accordingly. Such revisions in the estimates of the potential liabilities could have a material impact on the Company’s results of operations and financial position.
|
Goodwill and Intangible Assets |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets | Goodwill and Intangible Assets The following presents details of goodwill and intangible assets:
The $11.0 million increase for the nine months ended March 28, 2025 is associated with the purchase price allocations for the 4RF acquisition and the NEC Transaction. Refer to Note 11. Acquisitions for further information. The Company performs its annual goodwill impairment test on the first day of its fourth fiscal quarter. No indicators of impairment were identified during the current period that required the Company to perform an interim assessment or recoverability test.
Amortization of finite-lived intangibles for the three and nine months ended March 28, 2025 was $0.7 million and $2.0 million, respectively, and is included in selling and administrative expenses. There were no impairment charges recorded for the three and nine months ended March 28, 2025. As of March 28, 2025, the estimated future amortization expense of finite-lived intangible assets is as follows (in thousands):
|
Related Party Transactions |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions | Related Party Transactions NEC Corporation On the Closing Date, the Company completed the NEC Transaction. See Note 11. Acquisitions for further information. A portion of the total consideration in the NEC Transaction included the issuance of 736,750 shares in Company common stock to NEC. The Company and NEC entered into a Registration Rights and Lock-Up Agreement, restricting NEC’s ability to transfer shares (the “Lock-Up”), except for certain limited exceptions as provided in the Registration Rights and Lock-Up Agreement, until one day after the one-year anniversary of the Closing Date (the “Initial Lock-Up Expiration Date”). Starting one day after the Initial Lock-Up Expiration Date, one-twelfth of the issued shares shall be released from the Lock-Up each month, such that all issued shares shall be released from Lock-Up by the two-year anniversary of the Closing Date. Pursuant to the Purchase Agreement, NEC has the right to nominate a director to the Company’s Board of Directors from the Closing Date and for a period of two years thereafter. As of March 28, 2025, NEC held approximately 5.8% of the Company’s outstanding common stock. In connection with the closing of the NEC Transaction and as of the Closing Date, the Company and NEC entered into agreements covering the performance of certain post-closing services and licensing arrangements. The agreements include arrangements covering manufacturing services and product supply, transition services, distribution services, research and development services, and licensing of trademark and intellectual property (“IP”). The Manufacturing and Supply Agreement includes arrangements for NEC to manufacture and supply Pasolink products on behalf of and to the Company and its customers. The transition services agreements include arrangements for the Company and NEC to provide and receive certain transition services, primarily associated with administrative functions. The distribution services agreements includes arrangements where NEC will provide distribution services on behalf of and to the Company and its customers in certain international markets and territories. The Research and Development Cooperating Agreement for Existing Products includes arrangements for NEC to provide the Company certain services relating to development work to maintain existing products of the NEC business. The licensing agreements include arrangements where the Company will grant NEC a non-exclusive license to certain Pasolink trademarks in Japan, and NEC will grant the Company a non-exclusive, worldwide (excluding Japan) license to certain NEC IP, including mobile backhaul-related patents. The licensing agreements are royalty-free and perpetual. A summary of the related party activity between the Company and NEC is as follows:
As of March 28, 2025, the Company’s outstanding related party balances with NEC included in the unaudited condensed consolidated balance sheets are as follows:
|
Revisions to Prior Period Consolidated Financial Statements |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Changes and Error Corrections [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revisions to Prior Period Consolidated Financial Statements | Revisions to Prior Period Consolidated Financial Statements As described in Note 1. The Company and Basis of Presentation, subsequent to the third quarter of fiscal 2024, the Company identified certain errors in the quarterly financial statements for fiscal 2024 related to estimated total contract costs and progress to completion for an over-time arrangement. The Company identified additional errors impacting the quarterly financial statements for fiscal 2024 related to the recognition of revenue prior to performance obligations being met and related to journal entries recorded in error. In accordance with ASC 250, Accounting Changes and Error Corrections and SAB No. 99, Materiality and No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, the Company evaluated the materiality of the errors and determined that the impacts were not material, individually or in the aggregate, to the Company’s previously issued consolidated financial statements. The Company has revised the prior period financial statements and related disclosures for the third quarter of fiscal 2024 to correct the errors. A summary of the corrections to the impacted financial statement line items in the Company’s previously issued Consolidated Statements of Operations, Comprehensive Income, Equity and Cash Flows for the three and nine months ended March 29, 2024 is provided below. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (unaudited)
|
Pay vs Performance Disclosure - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Pay vs Performance Disclosure | ||||
Net (loss) income | $ 3,528 | $ 3,870 | $ (3,856) | $ 9,211 |
Insider Trading Arrangements |
3 Months Ended |
---|---|
Mar. 28, 2025
shares
| |
Trading Arrangements, by Individual | |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Erin Boase [Member] | |
Trading Arrangements, by Individual | |
Material Terms of Trading Arrangement | On March 7, 2025, Erin Boase, General Counsel, Vice President Legal Affairs, adopted a new trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The trading plan is intended to permit Ms. Boase to sell an aggregate of 11,770 shares. Ms. Boase’s plan is in effect until March 7, 2026.
|
Name | Erin Boase |
Title | General Counsel, Vice President Legal Affairs |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | March 7, 2025 |
Expiration Date | March 7, 2026 |
Arrangement Duration | 365 days |
Aggregate Available | 11,770 |
The Company and Basis of Presentation (Policies) |
9 Months Ended |
---|---|
Mar. 28, 2025 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information, and Aviat has made estimates, assumptions and judgments affecting the amounts reported in its unaudited condensed consolidated financial statements and the accompanying notes, as discussed in greater detail below. Accordingly, the statements do not include all information and footnotes required by U.S. GAAP for annual consolidated financial statements. In the opinion of the Company’s management, such interim financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of its financial position, results of operations and cash flows for such periods. The results for the nine months ended March 28, 2025 are not necessarily indicative of the results that may be expected for the full fiscal year or future operating periods. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and footnotes thereto included in Aviat’s Annual Report on Form 10-K for the fiscal year ended June 28, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and accounts have been eliminated. Certain amounts in the financial statements have been reclassified for comparative purposes to conform to the current period financial statement presentation. Aviat’s fiscal year includes 52 or 53 weeks and ends on the Friday nearest to June 30. The three months ended March 28, 2025 and March 29, 2024 both consisted of 13 weeks. Fiscal year 2025 contains 52 weeks and will end on June 27, 2025. Fiscal year 2024 contained 52 weeks and ended on June 28, 2024.
|
Use of Estimates | Use of Estimates The preparation of unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires the Company to make estimates, assumptions and judgments affecting the amounts reported and related disclosures. Estimates are based upon historical factors, current circumstances and the experience and judgment of the Company’s management. The Company evaluates estimates and assumptions on an ongoing basis and may employ outside experts to assist in making these evaluations. Changes in such estimates, based on more accurate information, or different assumptions or conditions, may affect amounts reported in future periods. Such estimates affect significant items, including revenue recognition, provision for uncollectible receivables, inventory valuation, goodwill and identified intangible assets in business combinations, valuation allowances for deferred tax assets, uncertainties in income taxes, contingencies and recoverability of long-lived assets. Actual results may differ materially from estimates.
|
Accounting Standards Not Yet Adopted | Accounting Standards Not Yet Adopted In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03 (Subtopic 220-40): Disaggregation of Income Statement Expenses. The ASU requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 is effective for the Company’s annual reporting beginning in fiscal 2028 and for interim periods beginning in fiscal 2029. The Company is currently evaluating the impact of this ASU on its consolidated financial statements and disclosures. In December 2023, the FASB ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU enhances the transparency and usefulness of income tax information through improvements to disclosures primarily related to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for the Company’s annual reporting beginning in fiscal 2026. The Company is currently evaluating the impact of this ASU on its consolidated financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses that are regularly presented to the chief operating decision maker. The disclosures required under ASU 2023-07 are also required for public entities with a single reportable segment. ASU 2023-07 is effective for the Company’s annual reporting beginning in fiscal 2025 and for interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of the ASU on its consolidated financial statements and disclosures. The Company considers the applicability and impact of all ASUs issued by the FASB. The Company determined at this time that all other ASUs issued but not yet adopted are either not applicable or are expected to have a minimal impact on its financial position and results of operations.
|
Fair Value Measurements | Items are classified within Level 1 if quoted prices are available in active markets. The Company’s Level 1 items are primarily money market funds and marketable securities. As of March 28, 2025 and June 28, 2024, the money market funds were valued at $1.00 net asset value per share. Items are classified within Level 2 if the observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources are available with reasonable levels of price transparency. The Company’s bank certificates of deposit are classified within Level 2. The carrying value of bank certificates of deposit approximates their fair value.
|
Net Income (Loss) Per Share of Common Stock (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Basic and Diluted Net Income (Loss) Per Share | The following table presents the computation of basic and diluted net income (loss) per share:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Antidilutive Securities Excluded from Computation of Net Income Per Share | The following table summarizes the weighted-average equity awards that were excluded from the diluted net income (loss) per share calculations since they were anti-dilutive:
|
Revenue Recognition (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Contract with Customer, Asset and Liability |
|
Balance Sheet Components (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Related Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash, Cash Equivalents and Restricted Cash | The following provides a summary of cash, cash equivalents, and restricted cash reported within the unaudited condensed consolidated balance sheets that reconciles to the corresponding amount in the unaudited condensed consolidated statement of cash flows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash, Cash Equivalents and Restricted Cash | The following provides a summary of cash, cash equivalents, and restricted cash reported within the unaudited condensed consolidated balance sheets that reconciles to the corresponding amount in the unaudited condensed consolidated statement of cash flows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventories |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Adjustments to Inventory | The charges incurred during the three and nine months ended March 28, 2025 and March 29, 2024 were included in cost of product sales as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Current Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Property, Plant and Equipment, Net |
Depreciation expense related to property, plant and equipment, was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accrued Expenses |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Changes in Warranty Liability | The Company accrues for the estimated cost to repair or replace products under warranty. Changes in the warranty liability were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Advance Payments and Unearned Income |
|
Fair Value Measurements of Assets and Liabilities (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, by Balance Sheet Grouping | The estimated fair values and valuation input levels of assets and liabilities that are measured at fair value on a recurring basis as of March 28, 2025 and June 28, 2024 were as follows:
|
Credit Facility and Debt (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Long-Term Debt | The following summarizes the Company’s outstanding long-term debt as of March 28, 2025:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Maturities of Long-Term Debt | As of March 28, 2025, scheduled maturities of outstanding long-term debt by fiscal year are as follows:
|
Restructuring (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restructuring-Related Activities | The following table summarizes restructuring related activities during the nine months ended March 28, 2025:
|
Stockholders’ Equity (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Compensation Expense for Share-based Compensation Awards | Total compensation expense for share-based awards included in the unaudited condensed consolidated statements of operations was as follows:
|
Segment and Geographic Information (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Revenue by Region | Revenue by region for the three and nine months ended March 28, 2025 and March 29, 2024 was as follows:
|
Acquisitions (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Preliminary Purchase Consideration | A summary of the preliminary purchase price allocation is as follows:
A summary of the final purchase price allocation is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Pro Forma Adjustments | The following unaudited supplemental pro forma information has been presented as if the NEC Transaction occurred at the beginning of fiscal 2023 and includes certain pro forma adjustments for interest expense, depreciation and amortization expense, the fair value of acquired inventory, and transaction costs, net of income tax:
|
Commitment and Contingencies (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Commercial Commitments | The following table presents details of the Company’s commercial commitments:
|
Goodwill and Intangible Assets (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets and Goodwill | The following presents details of goodwill and intangible assets:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill Impairment |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | As of March 28, 2025, the estimated future amortization expense of finite-lived intangible assets is as follows (in thousands):
|
Related Party Transactions (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Related Party Transactions | A summary of the related party activity between the Company and NEC is as follows:
As of March 28, 2025, the Company’s outstanding related party balances with NEC included in the unaudited condensed consolidated balance sheets are as follows:
|
Revisions to Prior Period Consolidated Financial Statements (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Changes and Error Corrections [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, Cash Flows, and Equity | A summary of the corrections to the impacted financial statement line items in the Company’s previously issued Consolidated Statements of Operations, Comprehensive Income, Equity and Cash Flows for the three and nine months ended March 29, 2024 is provided below. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (unaudited)
|
Net Income (Loss) Per Share of Common Stock (Schedule of Basic and Diluted Net Income (Loss) Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Numerator: | ||||
Net income (loss), basic | $ 3,528 | $ 3,870 | $ (3,856) | $ 9,211 |
Net income (loss), diluted | $ 3,528 | $ 3,870 | $ (3,856) | $ 9,211 |
Denominator: | ||||
Weighted-average shares outstanding, basic (in shares) | 12,689 | 12,555 | 12,672 | 12,043 |
Effect of potentially dilutive equivalent shares (in shares) | 149 | 224 | 0 | 282 |
Weighted-average shares outstanding, diluted (in shares) | 12,838 | 12,779 | 12,672 | 12,325 |
Net income (loss) per share of common stock outstanding: | ||||
Basic (in dollars per share) | $ 0.28 | $ 0.31 | $ (0.30) | $ 0.76 |
Diluted (in dollars per share) | $ 0.27 | $ 0.30 | $ (0.30) | $ 0.75 |
Net Income (Loss) Per Share of Common Stock (Schedule of Common Stock Excluded Because they were Antidilutive) (Details) - shares shares in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Total shares of common stock excluded (in shares) | 703 | 368 | 574 | 341 |
Stock options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Total shares of common stock excluded (in shares) | 308 | 337 | 374 | 315 |
Restricted stock units and performance stock units | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Total shares of common stock excluded (in shares) | 395 | 31 | 200 | 26 |
Revenue Recognition (Schedule of Contracted Balances) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Contract assets | ||
Accounts receivable, net | $ 178,036 | $ 158,013 |
Unbilled receivables | 101,406 | 90,525 |
Capitalized commissions | 3,745 | 3,269 |
Contract liabilities | ||
Advance payments and unearned revenue | 85,658 | 58,839 |
Unearned revenue, long-term | $ 7,670 | $ 7,413 |
Revenue Recognition (Narrative) (Details) $ in Millions |
3 Months Ended | 9 Months Ended |
---|---|---|
Mar. 28, 2025
USD ($)
|
Mar. 28, 2025
USD ($)
|
|
Disaggregation of Revenue [Line Items] | ||
Advance payments and unearned income | $ 93.3 | $ 93.3 |
Revenue to be recognized, percentage | 70.00% | 70.00% |
Services | ||
Disaggregation of Revenue [Line Items] | ||
Revenue recognized | $ 10.4 | $ 43.6 |
Revenue Recognition (Remaining Performance Obligations) (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-03-29 $ in Millions |
Mar. 28, 2025
USD ($)
|
---|---|
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, amount | $ 149.6 |
Remaining performance obligation, percentage | 50.00% |
Expected timing of satisfaction, period | 12 months |
Balance Sheet Components (Schedule of Cash, Cash Equivalents and Restricted Cash) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
Mar. 29, 2024 |
Jun. 30, 2023 |
---|---|---|---|---|
Balance Sheet Related Disclosures [Abstract] | ||||
Cash and cash equivalents | $ 49,429 | $ 64,622 | ||
Restricted cash included in long-term other assets | 2,250 | 312 | ||
Total cash, cash equivalents, and restricted cash | $ 51,679 | $ 64,934 | $ 58,479 | $ 22,521 |
Balance Sheet Components (Schedule of Inventories) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Balance Sheet Related Disclosures [Abstract] | ||
Finished products | $ 63,649 | $ 44,890 |
Raw materials and supplies | 27,621 | 15,433 |
Customer service inventories | 1,888 | 1,944 |
Total inventories | 93,158 | 62,267 |
Consigned inventories included within raw materials and supplies | $ 20,418 | $ 11,456 |
Balance Sheet Components (Schedule of Inventory Adjustments) (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Balance Sheet Related Disclosures [Abstract] | ||||
Excess and obsolete inventory | $ 565 | $ 2,251 | $ 1,178 | $ 2,937 |
Customer service inventory write-downs | 215 | 153 | 678 | 652 |
Total charges | $ 780 | $ 2,404 | $ 1,856 | $ 3,589 |
Balance Sheet Components (Schedule of Other Current Assets) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Balance Sheet Related Disclosures [Abstract] | ||
Prepaid and other current assets | $ 14,545 | $ 13,559 |
Taxes | 12,246 | 8,623 |
Contract manufacturing assets | 7,784 | 4,894 |
Other current assets | $ 34,575 | $ 27,076 |
Balance Sheet Components (Schedule of Property, Plant and Equipment) (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
Jun. 28, 2024 |
|
Property, Plant and Equipment [Line Items] | |||||
Total property, plant and equipment, gross | $ 80,849 | $ 80,849 | $ 71,200 | ||
Less: accumulated depreciation | (65,216) | (65,216) | (61,720) | ||
Total property, plant and equipment, net | 15,633 | 15,633 | 9,480 | ||
Depreciation | 1,169 | $ 1,004 | 3,959 | $ 3,077 | |
Buildings and leasehold improvements | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property, plant and equipment, gross | 1,889 | 1,889 | 1,302 | ||
Software and equipment | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property, plant and equipment, gross | $ 78,960 | $ 78,960 | $ 69,898 |
Balance Sheet Components (Narrative) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment, gross | $ 80,849 | $ 71,200 |
Unearned revenue | 7,670 | 7,413 |
Asset under construction | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment, gross | $ 7,700 | $ 4,100 |
Balance Sheet Components (Schedule of Accrued Expenses) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Balance Sheet Related Disclosures [Abstract] | ||
Taxes | $ 13,065 | $ 8,827 |
Compensation and benefits | 8,159 | 9,689 |
Project costs | 7,459 | 14,305 |
Other | 5,290 | 3,507 |
Warranties | 3,750 | 2,996 |
Commissions | 1,293 | 1,538 |
Professional fees | 1,509 | 1,286 |
Total accrued expenses | $ 40,525 | $ 42,148 |
Balance Sheet Components (Schedule of Accrued Warranties) (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Warranty Liability Roll Forward | ||||
Balance as of the beginning of the period | $ 3,926 | $ 2,746 | $ 2,996 | $ 2,100 |
Warranty provision recorded during the period | 230 | 587 | 1,488 | 1,601 |
Assumed in acquisition | 0 | 0 | 406 | 446 |
Consumption during the period | (406) | (537) | (1,140) | (1,351) |
Balance as of the end of the period | $ 3,750 | $ 2,796 | $ 3,750 | $ 2,796 |
Balance Sheet Components (Schedule of Advance Payments and Unearned Revenue) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Balance Sheet Related Disclosures [Abstract] | ||
Advance payments | $ 11,041 | $ 8,517 |
Unearned revenue | 74,617 | 50,322 |
Total advance payments and unearned revenue | $ 85,658 | $ 58,839 |
Fair Value Measurements of Assets and Liabilities (Schedule of Fair Value, by Balance Sheet Grouping) (Details) - Estimate of Fair Value Measurement - Recurring - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Money market funds | Level 1 | ||
Assets: | ||
Cash and cash equivalents: | $ 2,256 | $ 6,602 |
Bank certificates of deposit | Level 2 | ||
Assets: | ||
Cash and cash equivalents: | $ 4,740 | $ 3,706 |
Fair Value Measurements of Assets and Liabilities (Narrative) (Details) - $ / shares |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Money market funds | Level 1 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Money market, net asset value (in dollars per share) | $ 1.00 | $ 1.00 |
Credit Facility and Debt - (Schedule of Long-Term Debt) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Debt Instrument [Line Items] | ||
Long-term debt, gross | $ 74,063 | |
Less: unamortized deferred financing costs | (140) | |
Total | 73,923 | |
Less: current portion of long-term debt | (3,719) | $ (2,396) |
Total long-term debt | 70,204 | $ 45,954 |
Line of Credit | Revolver | ||
Debt Instrument [Line Items] | ||
Long-term debt, gross | 0 | |
Line of Credit | Term loan | ||
Debt Instrument [Line Items] | ||
Long-term debt, gross | $ 74,063 |
Credit Facility and Debt - (Schedule of Maturities of Long-Term Debt) (Details) $ in Thousands |
Mar. 28, 2025
USD ($)
|
---|---|
Debt Disclosure [Abstract] | |
Remainder of 2025 | $ 938 |
2026 | 4,688 |
2027 | 6,562 |
2028 | 1,875 |
2029 | 0 |
2030 | 60,000 |
Total | $ 74,063 |
Restructuring (Schedule of Restructuring Related Activities) (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 28, 2025 |
Dec. 27, 2024 |
Sep. 27, 2024 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Restructuring Reserve [Roll Forward] | ||||||
Accrual balance, beginning of period | $ 650 | $ 1,638 | $ 1,718 | $ 1,718 | ||
Charges, net | 177 | 1,415 | $ (417) | 1,592 | $ 2,227 | |
Cash payments | (741) | (2,403) | (80) | |||
Accrued balance, end of period | 86 | 650 | 1,638 | 86 | ||
Employee Severance and Benefits | ||||||
Restructuring Reserve [Roll Forward] | ||||||
Accrual balance, beginning of period | 650 | 1,638 | 1,718 | 1,718 | ||
Charges, net | 177 | 1,415 | ||||
Cash payments | (741) | (2,403) | (80) | |||
Accrued balance, end of period | 86 | 650 | 1,638 | 86 | ||
Facilities and Other | ||||||
Restructuring Reserve [Roll Forward] | ||||||
Accrual balance, beginning of period | 0 | 0 | 0 | 0 | ||
Charges, net | 0 | 0 | ||||
Cash payments | 0 | 0 | 0 | |||
Accrued balance, end of period | $ 0 | $ 0 | $ 0 | $ 0 |
Restructuring (Narrative) (Details) $ in Millions |
Mar. 28, 2025
USD ($)
|
---|---|
Restructuring and Related Activities [Abstract] | |
Restructuring liabilities | $ 0.1 |
Segment and Geographic Information (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025
USD ($)
|
Mar. 29, 2024
USD ($)
|
Mar. 28, 2025
USD ($)
segment
|
Mar. 29, 2024
USD ($)
|
|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Number of reportable segments | segment | 1 | |||
Total revenue | $ 112,640 | $ 110,822 | $ 319,266 | $ 291,423 |
North America | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Total revenue | 49,402 | 44,400 | 149,589 | 149,868 |
Africa and the Middle East | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Total revenue | 15,086 | 11,401 | 38,210 | 35,848 |
Europe | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Total revenue | 9,429 | 6,549 | 23,376 | 17,378 |
Latin America and Asia Pacific | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Total revenue | $ 38,723 | $ 48,472 | $ 108,091 | $ 88,329 |
Acquisitions (Narrative) (Details) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|---|
Jul. 02, 2024 |
Nov. 30, 2023 |
Nov. 30, 2023 |
Dec. 27, 2024 |
Mar. 28, 2025 |
|
4RF Limited | |||||
Business Acquisition [Line Items] | |||||
Payments to acquire businesses, net of cash acquired | $ 18.2 | ||||
Cash acquired | 1.2 | ||||
Finite-lived intangible assets, period increase (decrease) | (0.9) | ||||
Increase (decrease) in other assets | 0.2 | ||||
Goodwill, period increase (decrease) | $ 0.7 | ||||
NEC Corporation | |||||
Business Acquisition [Line Items] | |||||
Payments to acquire businesses, net of cash acquired | $ 5.8 | ||||
Payments to acquire businesses | $ 32.2 | $ 13.2 | |||
Consideration transferred, equity interest issued and issuable, number of shares (in shares) | 736,750 | ||||
Consideration transferred, equity interest issued and issuable | $ 22.3 | 22.3 | |||
Total net consideration | $ 54.5 |
Acquisitions (Schedule of Pro Forma Adjustments) (Details) - NEC Corporation - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended |
---|---|---|
Mar. 29, 2024 |
Mar. 29, 2024 |
|
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Revenue | $ 110,822 | $ 376,336 |
Net income | $ 4,844 | $ 17,654 |
Commitments and Contingencies (Narrative) (Details) $ in Thousands |
9 Months Ended |
---|---|
Mar. 28, 2025
USD ($)
| |
Other Commitments [Line Items] | |
Commercial commitments outstanding | $ 24,076 |
Maximum | |
Other Commitments [Line Items] | |
Guarantee term | 2 years |
Purchase Obligations with Suppliers of Contract Manufacturers | |
Other Commitments [Line Items] | |
Purchase obligation | $ 45,000 |
Contractual Obligations Associated with Software as Service and Software | |
Other Commitments [Line Items] | |
Purchase obligation | $ 6,500 |
Commitments and Contingencies (Schedule of Commercial Commitments) (Details) $ in Thousands |
Mar. 28, 2025
USD ($)
|
---|---|
Commitments and Contingencies Disclosure [Abstract] | |
Letters of credit | $ 8,700 |
Bonds | 15,376 |
Total | $ 24,076 |
Goodwill and Intangible Assets (Schedule of Intangible Assets and Goodwill) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Goodwill | $ 19,188 | $ 8,217 |
Goodwill and Intangible Assets (Narrative) (Details) - USD ($) |
3 Months Ended | 9 Months Ended | |
---|---|---|---|
Mar. 28, 2025 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Goodwill acquired | $ 11,000,000.0 | ||
Goodwill, impairment | 0 | ||
Amortization of intangible assets | $ 700,000 | 1,976,000 | $ 651,000 |
Impairment charges | $ 0 | $ 0 |
Goodwill and Intangible Assets (Schedule of Finite-Lived Intangible Assets, Future Amortization Expense) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Remainder of 2025 | $ 704 | |
2026 | 2,814 | |
2027 | 2,814 | |
2028 | 2,720 | |
2029 | 2,720 | |
Thereafter | 15,045 | |
Total | $ 26,817 | $ 13,644 |
Related Party Transactions (Narrative) (Details) |
Nov. 30, 2023
shares
|
Mar. 28, 2025 |
---|---|---|
NEC Transaction | NEC Corporation | ||
Related Party Transaction [Line Items] | ||
Equity method investment, ownership percentage | 5.80% | |
Lock-Up | Related Party | ||
Related Party Transaction [Line Items] | ||
Share release, monthly release of issued shares | 0.0833 | |
Share release, period after closing date | 2 years | |
NEC Corporation | ||
Related Party Transaction [Line Items] | ||
Consideration transferred, equity interest issued and issuable, number of shares (in shares) | 736,750 |
Related Party Transactions (Schedule of Related Party Transactions) (Details) - NEC Corporation - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Transition services received | ||||
Related Party Transaction [Line Items] | ||||
Related party transaction, amounts of transaction | $ 1,131 | $ 1,152 | $ 3,026 | $ 2,236 |
Research and development services received | ||||
Related Party Transaction [Line Items] | ||||
Related party transaction, amounts of transaction | 0 | 3,220 | 5,401 | 4,303 |
Purchase of inventories | ||||
Related Party Transaction [Line Items] | ||||
Related party transaction, amounts of transaction | $ 12,407 | $ 4,783 | $ 35,746 | $ 4,783 |
Related Party Transactions (Schedule of Related Party Transactions Balance Sheets) (Details) - USD ($) $ in Thousands |
Mar. 28, 2025 |
Jun. 28, 2024 |
---|---|---|
Related Party Transaction [Line Items] | ||
Accounts receivable, net | $ 178,036 | $ 158,013 |
Accounts payable | 137,730 | 92,854 |
Other current liabilities | 13,299 | $ 21,614 |
NEC Corporation | Related Party | ||
Related Party Transaction [Line Items] | ||
Accounts receivable, net | 1,102 | |
Accounts payable | 38,511 | |
Other current liabilities | $ 13,213 |
Revisions to Prior Period Consolidated Financial Statements (CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited) (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Net income | $ 3,528 | $ 3,870 | $ (3,856) | $ 9,211 |
Comprehensive income | ||||
Comprehensive income (loss) | $ 4,636 | 3,529 | $ (4,011) | 9,448 |
As Previously Reported | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Net income | 3,418 | 10,313 | ||
Comprehensive income | ||||
Comprehensive income (loss) | 3,077 | 10,550 | ||
Adjustments | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Net income | 452 | (1,102) | ||
Comprehensive income | ||||
Comprehensive income (loss) | $ 452 | $ (1,102) |
Revisions to Prior Period Consolidated Financial Statements (CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (unaudited) (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 28, 2025 |
Mar. 29, 2024 |
Mar. 28, 2025 |
Mar. 29, 2024 |
|
Change in Stockholders' Equity [Roll Forward] | ||||
Beginning balance | $ 249,587 | $ 251,023 | $ 255,885 | $ 218,739 |
Net income | 3,528 | 3,870 | (3,856) | 9,211 |
Ending balance | 256,116 | 256,046 | 256,116 | 256,046 |
Accumulated Deficit | ||||
Change in Stockholders' Equity [Roll Forward] | ||||
Beginning balance | (585,897) | (583,932) | (578,513) | (589,273) |
Net income | 3,528 | 3,870 | (3,856) | 9,211 |
Ending balance | $ (582,369) | (580,062) | $ (582,369) | (580,062) |
As Previously Reported | ||||
Change in Stockholders' Equity [Roll Forward] | ||||
Beginning balance | 253,936 | 220,098 | ||
Net income | 3,418 | 10,313 | ||
Ending balance | 258,507 | 258,507 | ||
As Previously Reported | Accumulated Deficit | ||||
Change in Stockholders' Equity [Roll Forward] | ||||
Beginning balance | (581,019) | (587,914) | ||
Net income | 3,418 | 10,313 | ||
Ending balance | (577,601) | (577,601) | ||
Adjustments | ||||
Change in Stockholders' Equity [Roll Forward] | ||||
Beginning balance | (2,913) | (1,359) | ||
Net income | 452 | (1,102) | ||
Ending balance | (2,461) | (2,461) | ||
Adjustments | Accumulated Deficit | ||||
Change in Stockholders' Equity [Roll Forward] | ||||
Beginning balance | (2,913) | (1,359) | ||
Net income | 452 | (1,102) | ||
Ending balance | $ (2,461) | $ (2,461) |
,P!W(LPB+"@VDU0U3BJFL!24T.D0W.>G #_),%@4Q@AH?.YZ#C4@B[*_7W"^L[;!E*HP\JXH_
M5%XOC@?)@.5R)IJBOJL>W\G.GI#X955A['_VV-Z-^(!EC:FK94<,#9:J;)_B
MJ?-#CR#Y$H'7$7A6[U:0U?)X>
MUN?I/;G?GE[ED&ZE(+.F J:#WGS:$2Z]=--'L'5\7>)>P3LJ#DO\JY(8N^M&^D=O.VR9
CE3,A^C!K34(:?\X.D*7+$NM')[:SVCVZ.= +>1F
M8]5&>B5Z;NE$#2&3Y'5*P$B5=M2&W9#4GTQ&41O44<.9]V6""D*#;2GCCF2D
M[T,F$>)2=2!;%54.9 20'%%%E9N]HC@B(Z4I3]L[R$U#LZ VGD3+/A#2\H(>
M$&7BR2M^3G?Y.GKUM[F&3=6S1-7[90_-MI+]A[
M,#2],S:;7/^)[UKZ2;S3N5*O*M;BF $ 9=_6[U:6."Q\=[NA:K]B%7Y48W
M-WV?W;8G<>$*+JM2A/N3=/>K,=O'T+\[8']S?#X0\S"8GRP'$W1X&H3+T^>,
MT(OH]+\R0I_ZB;D;H2->&(S,X7S?P#R+@ME)^/R).9B=AGMGYD6P.%WV9N;9
M-%C@QOU#\Q+S>SCU^<>04Y7H2J.MBL*7+O)9:01WI7YWZJ9H_A&6*Q%6]'["
M9&*NR"V_6JD-&&7-L+IN%K'1=3FW7;MO%>B/XA1SF@
%Z!4R,
M$3E$$PR7(_-2X&N7.L5Y2(LD;=T1\*_6=":Q84U%1!P+)%\(=>P+L